| RS2512577738 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS2512577776 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS2512577871 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS2512577883 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS2512579074 |
ADAMTS10
|
Health Risk |
Pathogenic |
— |
| RS2512579975 |
BRD4
|
Health Risk |
Likely pathogenic |
See cases, Cornelia de Lange syndrome 6 |
| RS2512580369 |
BRD4
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 6, Cornelia de Lange syndrome 6 |
| RS2512581936 |
TYK2
|
Health Risk |
Pathogenic |
Immunodeficiency 35, Immunodeficiency 35 |
| RS2512582393 |
TYK2
|
Health Risk |
Pathogenic |
Immunodeficiency 35, Immunodeficiency 35 |
| RS2512591789 |
ADAMTS10
|
Health Risk |
Pathogenic |
— |
| RS2512592873 |
ADAMTS10
|
Health Risk |
Pathogenic |
— |
| RS2512594998 |
ADAMTS10
|
Health Risk |
Likely pathogenic |
— |
| RS2512600587 |
KLF2
|
Health Risk |
Likely pathogenic, low penetrance |
Inherited Immunodeficiency Diseases, Inherited Immunodeficiency Diseases |
| RS2512602579 |
RTTN
|
Health Risk |
Pathogenic |
Microcephalic primordial dwarfism due to RTTN deficiency, Microcephalic primordial dwarfism due to RTTN deficiency |
| RS2512603336 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2512608847 |
ADAMTS10
|
Health Risk |
Pathogenic |
— |
| RS2512609711 |
NOTCH3
|
Health Risk |
Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2512609739 |
NOTCH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Lateral meningocele syndrome, Lateral meningocele syndrome |
| RS2512610959 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2512612604 |
TNPO2
|
Health Risk |
Likely pathogenic |
— |
| RS2512618280 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2512622286 |
ADAMTS10
|
Health Risk |
Likely pathogenic |
Weill-Marchesani syndrome 1, Weill-Marchesani syndrome 1 |
| RS2512623267 |
RTTN
|
Health Risk |
Likely pathogenic |
— |
| RS2512623887 |
NOTCH3
|
Health Risk |
Likely pathogenic |
NOTCH3-related disorder, NOTCH3-related disorder |
| RS2512627196 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 6, Spinocerebellar ataxia type 6 |
| RS2512627299 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2512636728 |
NOTCH3
|
Health Risk |
Pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2512636980 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS2512637222 |
FBN3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2512637780 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS2512639575 |
ADAMTS10
|
Health Risk |
Likely pathogenic |
Weill-Marchesani syndrome 1, Weill-Marchesani syndrome 1 |
| RS2512640171 |
ADAMTS10
|
Health Risk |
Pathogenic |
— |
| RS2512644040 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS2512644126 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2512644131 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2512645497 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2512645777 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS2512645913 |
BPTF
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2512646581 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS2512646880 |
BPTF
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies |
| RS2512649059 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2512649193 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2512649411 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS2512652630 |
TNPO2
|
Health Risk |
Likely pathogenic |
TNPO2-related disorder, TNPO2-related disorder |
| RS2512657457 |
NOTCH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2512657590 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2512657786 |
NOTCH3
|
Health Risk |
Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2512658095 |
NOTCH3
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2512659319 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS2512659535 |
NOTCH3
|
Health Risk |
Likely pathogenic |
— |
| RS2512659895 |
NOTCH3
|
Health Risk |
Likely pathogenic |
— |
| RS2512661013 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS2512661018 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2512661152 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS2512661234 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS2512661812 |
NOTCH3
|
Health Risk |
Likely pathogenic |
— |
| RS2512663904 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2512664094 |
PET100
|
Health Risk |
Likely pathogenic |
— |
| RS2512664250 |
NOTCH3
|
Health Risk |
Likely pathogenic |
— |
| RS2512664352 |
TCF4
|
Health Risk |
Likely pathogenic |
Corneal dystrophy, Fuchs endothelial |
| RS2512665006 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS2512665125 |
NOTCH3
|
Health Risk |
Pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2512665397 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS2512665717 |
NOTCH3
|
Health Risk |
Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2512666442 |
NOTCH3
|
Health Risk |
Pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2512666940 |
TCF4
|
Health Risk |
Pathogenic |
Corneal dystrophy, Fuchs endothelial |
| RS2512666971 |
NOTCH3
|
Health Risk |
Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS2512672832 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS2512683140 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512684973 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512689549 |
TPM4
|
Health Risk |
Pathogenic |
Bleeding disorder, platelet-type |
| RS2512689722 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2512691532 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512691552 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512691573 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512691704 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512691738 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512692673 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512693319 |
GPX4
|
Health Risk |
Likely pathogenic |
Spondylometaphyseal dysplasia, Sedaghatian type |
| RS2512695145 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512695846 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512697088 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512697589 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512698714 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512699538 |
MUC16
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS2512699658 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512700267 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512700288 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512700296 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512700352 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512700357 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512700824 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512700995 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512703983 |
BRD4
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2512704609 |
BRD4
|
Health Risk |
Pathogenic |
— |
| RS2512705295 |
TNPO2
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with hypotonia, impaired speech |
| RS2512705615 |
TNPO2
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with hypotonia, impaired speech |
| RS2512705724 |
BRD4
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 6, Cornelia de Lange syndrome 6 |
| RS2512705792 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2512706058 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |